HomeSENORES • NSE
add
Senores Pharmaceuticals Ltd
Previous close
₹571.05
Day range
₹563.25 - ₹578.20
Year range
₹435.25 - ₹665.00
Market cap
26.09B INR
Avg Volume
243.29K
P/E ratio
35.15
Dividend yield
-
Primary exchange
NSE
Market news
Financials
Income Statement
Revenue
Net income
| (INR) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 1.14B | 11.49% |
Operating expense | 425.40M | 10.84% |
Net income | 178.30M | 11.86% |
Net profit margin | 15.61 | 0.32% |
Earnings per share | — | — |
EBITDA | 184.20M | -9.09% |
Effective tax rate | 13.10% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 3.86B | 2,898.83% |
Total assets | 12.27B | 97.28% |
Total liabilities | 4.15B | 6.26% |
Total equity | 8.12B | — |
Shares outstanding | 46.80M | — |
Price to book | 3.40 | — |
Return on assets | — | — |
Return on capital | 4.19% | — |
Cash Flow
Net change in cash
| (INR) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 178.30M | 11.86% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
2017
Website
Employees
145
